OptiLight by Lumenis is a light-based, non-invasive treatment focused on the skin around the eyes to manage dry eye. The first and only IPL FDA-approved for dry eye management. The treatment is safe, gentle, and is backed by more than 20 clinical studies.
OptiLight with Lumenis patented Optimal Pulse Technology uses precise, intense broad spectrum light to address the inflammation – one of the key underlining factors in dry eye disease due to MGD. OptiLight was specifically developed to reach the delicate contours of the treated area safely, effectively and gently. OptiLight sets new treatment standards and helps patients to regain health, control and joy. Backed by numerous clinical studies, OptiLight’s novel optimal pulse technology(OPT) provides a transformative, safe, and efficacious way to improve Dry Eye disease due to MGD.
